A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11280793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

  2005cited by this paper
• Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.

  2000cited by this paper
• Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

  2000cited by this paper
• Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.

  2000influential reference
• Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis

  1999cited by this paper
• Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry.

  1999cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma

  1999cited by this paper
• Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.

  1998cited by this paper
• Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

  1998cited by this paper
• A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

  1998influential reference
• Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  1998cited by this paper
• Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: New perspectives

  1998cited by this paper
• Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.

  1998cited by this paper
• Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.

  1998cited by this paper
• Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line

  1998cited by this paper
• Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.

  1998cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma: An update

  1998cited by this paper
• Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

  1998cited by this paper
• Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes.

  1998cited by this paper
• Prostate cancer progression, metastasis, and gene expression in transgenic mice.

  1997cited by this paper
• Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma.

  1997cited by this paper
• p53 protein and gene alterations in pathological stage C prostate carcinoma.

  1997cited by this paper
• Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice

  1997cited by this paper
• Molecular biology of prostatic intraepithelial neoplasia

  1996cited by this paper
• Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.

  1996cited by this paper
• Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells.

  1996cited by this paper
• Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.

  1996cited by this paper
• Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.

  1996cited by this paper
• Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia

  1996cited by this paper
• Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model

  1996cited by this paper
• The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens

  1996cited by this paper
• Prostate cancer in a transgenic mouse.

  1995influential reference
• Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.

  1995cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma. Recent findings and new concepts

  1995cited by this paper
• Interobserver Reproducibility in the Diagnosis of Prostatic Intraepithelial Neoplasia

  1995cited by this paper
• Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

  1994cited by this paper
• The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice.

  1994cited by this paper
• BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.

  1994cited by this paper
• Do neuroendocrine cells in human prostate cancer express androgen receptor?

  1993cited by this paper
• The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue.

  1993cited by this paper
• p53 expression in incidental prostatic cancer.

  1993cited by this paper
• Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.

  1993cited by this paper
• The neuroendocrine cell population of the human prostate gland.

  1993cited by this paper
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

  1992cited by this paper
• Prostatic intraepithelial neoplasia: A premalignant lesion

  1992cited by this paper
• Prostatic intraepithelial neoplasia: a premalignant lesion.

  1992cited by this paper
• Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.

  1992cited by this paper
• Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate

  1991cited by this paper
• Restriction of neuroblastoma to the prostate gland in transgenic mice

  1991cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products.

  1990cited by this paper
• Tumor suppressor genes

  1990cited by this paper
• Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin.

  1989cited by this paper
• Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma

  1988cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma.

  1987cited by this paper
• Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases

  1987influential reference
• Regulation of prostatic genes: role of androgens and zinc in gene expression.

  1986cited by this paper
• Sites of in vivo acetylation in trout testis histone IV.

  1971cited by this paper
• [Cell kinetics].

  1968cited by this paper

• Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer.

  2024cites this paper
• Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

  2024cites this paper
• Metastatic hormone-naïve prostate cancer: a distinct biological entity

  2024cites this paper
• Growth Hormone Action as a Target in Cancer: Significance, Mechanisms and Possible Therapies.

  2024cites this paper
• Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.

  2022cites this paper
• Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

  2022cites this paper
• Preclinical Models of Neuroendocrine Neoplasia

  2022cites this paper
• Appraising Animal Models of Prostate Cancer for Translational Research: Future Directions

  2022cites this paper
• An overview of the latest in state-of-the-art murine models for prostate cancer

  2021cites this paper
• Brain metastasis from large cell neuroendocrine carcinoma of the prostate: A case report and literature review

  2020cites this paper
• Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis

  2020cites this paper
• The Altered Metabolic Molecular Signatures Contribute to the RAD001 Resistance in Gastric Neuroendocrine Tumor

  2020cites this paper
• The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

  2020cites this paper
• The Current Status of Prostate Cancer Animal Models

  2020cites this paper
• Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells

  2020cites this paper
• Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research

  2020cites this paper
• Cells of Origin for Prostate Cancer.

  2019cites this paper
• Association Between Simian Virus 40 and Human Tumors

  2019cites this paper
• The great escape: tumour cell plasticity in resistance to targeted therapy

  2019cites this paper
• Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches

  2019cites this paper
• Sustained density of neuroendocrine cells with aging precedes development of prostatic hyperplasia in spontaneously hypertensive rats

  2019cites this paper
• A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host

  2019cites this paper
• The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

  2019cites this paper
• Lineage plasticity-mediated therapy resistance in prostate cancer

  2018cites this paper
• Overview of Genetically Engineered Mouse Models of Prostate Cancer and Their Applications in Drug Discovery

  2018cites this paper
• Mechanisms of treatment induced cell plasticity in prostate cancer

  2018cites this paper
• The Use of Endogenous and Synthetic Cannabinoids in Prostate Cancer Therapy

  2018cites this paper
• Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors.

  2018cites this paper
• Imaging the Unimaginable: Desorption Electrospray Ionization – Imaging Mass Spectrometry (DESI-IMS) in Natural Product Research

  2018cites this paper
• Cellular plasticity and the neuroendocrine phenotype in prostate cancer

  2018cites this paper
• Potential use of Aneustat for improvement of docetaxel-based therapy of advanced prostate cancer

  2017cites this paper
• Biology and evolution of poorly differentiated neuroendocrine tumors

  2017cites this paper
• Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

  2017cites this paper
• Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression

  2016cites this paper
• Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.

  2016cites this paper
• Does BFR1, a component of the transcription factor (TFIIIB), have a role in prostate carcinogenesis?

  2016cites this paper
• How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression.

  2016cites this paper
• Notch signaling in prostate cancer: refining a therapeutic opportunity.

  2016cites this paper
• de Brot, Simone and Ntekim, Atara and Cardenas, Ryan and James, Victoria and Allegrucci, Cinzia and Heery, David M. and Bates, David O. and Ødum, Niels and Persson, Jenny L. and Mongan,

  2016cites this paper
• Informatics for Mass Spectrometry-Based Protein Characterization

  2015cites this paper
• Regulation of vascular endothelial growth factor ( VEGF ) in prostate cancer 1 2

  2015cites this paper
• In vitro and in vivo model systems used in prostate cancer research.

  2015cites this paper
• Capsaicin as a Novel Chemopreventive and Therapeutic Option for Prostate Cancer

  2015cites this paper
• Analysis of Metabolic Changes in Plant Pathosystems by Imprint Imaging DESI-MS

  2015cites this paper
• Regulation of vascular endothelial growth factor in prostate cancer.

  2015cites this paper
• The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

  2015cites this paper
• Rodent models for human diseases.

  2015cites this paper
• Metastatic phenotype in CWR22 prostate cancer xenograft following castration

  2015cites this paper
• Prostate Cancer and Bone: The Elective Affinities

  2014cites this paper
• Models of neuroendocrine prostate cancer.

  2014cites this paper
• Neuroendocrine (small-cell) carcinomas: why they teach us essential lessons about prostate cancer.

  2014cites this paper
• Mouse models of prostate cancer: picking the best model for the question

  2014cites this paper
• A rare case of large cell neuroendocrine carcinoma

  2014cites this paper
• Single luminal epithelial progenitors can generate prostate organoids in culture

  2014cites this paper
• SV40 TAg mouse models of cancer.

  2014cites this paper
• SOX2 expression in the developing, adult, as well as diseased prostate

  2014cites this paper
• Cell and Developmental Biology

  2014cites this paper
• Zoledronic acid but not somatostatin analogs exerts anti‐tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration‐resistant prostate cancer

  2013cites this paper
• Detection and Organ-Specific Ablation of Neuroendocrine Cells by Synaptophysin Locus-Based BAC Cassette in Transgenic Mice

  2013cites this paper
• Xenograft, Transgenic, and Knockout Models of Prostate Cancer

  2013cites this paper
• FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.

  2013cites this paper
• Genetically engineered mouse models of prostate cancer

  2013cites this paper
• Imaging Mass Spectrometry of Proteins and Peptides

  2013cites this paper
• Current mouse and cell models in prostate cancer research.

  2013cites this paper
• Murine Models of Prostate Cancer

  2013cites this paper
• A Glance at the Complexity of Nutrition and the Prostate: Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• THE EFFECTS OF FIBROBLAST GROWTH FACTOR 8b ON REPRODUCTIVE ORGANS AND PROSTATE TUMORIGENESIS

  2013cites this paper
• Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic

  2013cites this paper
• Genetically Modified Animal Models

  2013cites this paper
• Chapter 8 A Glance at the Complexity of Nutrition and the Prostate : Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• Modeling prostate cancer in mice: limitations and opportunities.

  2012cites this paper
• Merkel cell polyomavirus positive merkel cell carcinoma -- from diagnosis to therapy

  2012cites this paper
• MALDI Imaging Mass Spectrometry

  2012cites this paper
• Targeting Notch signaling for cancer therapeutic intervention.

  2012cites this paper
• Matrix-Assisted Laser Desorption/Ionization Imaging Mass Spectrometry: A Promising Technique for Reproductive Research1

  2012cites this paper
• The Tumor Pathology of Genetically Engineered Mice: Genomic Pathology

  2012cites this paper
• Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression

  2012cites this paper
• Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.

  2012cites this paper
• Animal modeling of cancer pathology and studying tumor response to therapy.

  2012cites this paper
• The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice

  2012cites this paper
• Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer

  2011cites this paper
• Proteolytic Processing of Laminin-332 by Hepsin and Matriptase and Its Role in Prostate Cancer Progression

  2011cites this paper
• Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.

  2011cites this paper
• Tea polyphenols as prostate cancer preventive agents

  2011cites this paper
• Imaging Mass Spectrometry

  2011cites this paper
• THE EFFECT OF FINASTERIDE AND DUTASTERIDE ON THE GROWTH OF WPE1- NA22 PROSTATE CANCER XENOGRAFTS IN NUDE MICE by ALEXANDER

  2011cites this paper
• Overview of prostate anatomy, histology, and pathology.

  2011cites this paper
• A novel non-toxic xylene substitute (SBO) for histology.

  2011cites this paper
• Mouse Models of Prostate Cancer

  2011cites this paper
• Simian virus 40 transformation, malignant mesothelioma and brain tumors

  2011cites this paper
• Transgenic Expression of Polyomavirus Middle T Antigen in the Mouse Prostate Gives Rise to Carcinoma

  2011cites this paper
• Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact

  2011cites this paper
• A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.

  2011cites this paper
• Evaluation of a Delay-Line Detector Combined with Analog-to-Digital Converters as the Ion Detection System for Stigmatic Imaging Mass Spectrometry

  2011cites this paper
• Modeling human prostate cancer in genetically engineered mice.

  2011cites this paper
• Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

  2010cites this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010influential citation
• Molecular characterization of the Gγ‐globin‐Tag transgenic mouse model of hormone refractory prostate cancer: Comparison to human prostate cancer

  2010cites this paper
• Mechanisms of prostate cancer initiation and progression.

  2010cites this paper
• MYC and Prostate Cancer.

  2010cites this paper